Literature DB >> 19773639

Renal cell carcinoma in association with IgA nephropathy in the elderly.

Imari Mimura1, Akihiro Tojo, Satoshi Kinugasa, Hiroshi Uozaki, Toshiro Fujita.   

Abstract

IgA nephropathy can occur as a paraneoplastic syndrome of renal cell carcinoma. We report 3 cases of IgA nephropathy associated with renal cell carcinoma in the elderly patients and demonstrate that infiltrating lymphocytes and plasma cells around renal cell carcinoma produce IgA that likely contributed to mesangial IgA deposition.

Entities:  

Mesh：

Year:  2009        PMID： 19773639     DOI： 10.1097/MAJ.0b013e3181ae1b12

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis.

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

2.  Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma.

Authors:  Chen Cai; Jin Zhang; Minyu Li; Zhen-Jie Wu; Ken H Song; Tina W Zhan; Lin-Hui Wang; Ying-Hao Sun
Journal:  Tumour Biol       Date:  2015-12-30

3.  Paraneoplastic Glomerulopathy in a Case of Collecting Duct Renal Cell Carcinoma.

Authors:  Srikanth Prasad Devarsetty; Dharshan Rangaswamy; Shailaja Bhat; Shankar Prasad Nagaraju; Ravindra Prabhu Attur
Journal:  J Clin Diagn Res       Date:  2017-02-01

4.  Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma.

Authors:  Viral Patel; Roy Elias; Joseph Formella; William Schwartzman; Alana Christie; Qi Cai; Venkat Malladi; Payal Kapur; Miguel Vazquez; Renee McKay; Ivan Pedrosa; Raquibul Hannan; Hans Hammers; James Brugarolas
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

5.  Triple negative breast cancer and immunoglobulin A nephropathy: A case report and literature review.

Authors:  Da Jiang; Xue Zhang; Jiayin Liu; Yanzhi Cui; Ying Li; Fei Zheng
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.